1000342-65-3 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1H-Pyrrolo[3,2-c]pyridine, 3-chlorois used as a key building block for the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows for the development of new compounds with potential therapeutic and pesticidal properties, contributing to advancements in drug discovery and crop protection.
Used in Antiviral and Anticancer Research:
1H-Pyrrolo[3,2-c]pyridine, 3-chlorois utilized as a potential antiviral and anticancer agent in biological research. Its chemical properties make it a promising candidate for the development of new treatments against viral infections and cancer, offering new avenues for therapeutic intervention.
Used in Organic Light-Emitting Diodes (OLEDs) and Electronic Applications:
1H-Pyrrolo[3,2-c]pyridine, 3-chlorois employed in the development of organic light-emitting diodes (OLEDs) and other electronic applications due to its distinctive structural and electronic characteristics. Its integration into these technologies can enhance performance and contribute to the advancement of electronic devices and displays.
Check Digit Verification of cas no
The CAS Registry Mumber 1000342-65-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,3,4 and 2 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1000342-65:
(9*1)+(8*0)+(7*0)+(6*0)+(5*3)+(4*4)+(3*2)+(2*6)+(1*5)=63
63 % 10 = 3
So 1000342-65-3 is a valid CAS Registry Number.
1000342-65-3Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS
-
Paragraph 0484; 0486, (2014/06/23)
The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A′ B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.
HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS
-
Page/Page column 81, (2012/12/13)
The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A' B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.
